Skip to main navigation menu Skip to main content Skip to site footer

Journal History

Foundation and Vision

The International Journal of NeuroOncology and Therapeutics was established with a clear mission in 2024: to bridge the gap between neuro-oncology research and clinical practices worldwide. Recognizing the critical need for a dedicated platform in this specialized field, a consortium of leading researchers and healthcare practitioners came together to create a journal that not only publishes cutting-edge research but also fosters collaboration and dialogue among neuro-oncology professionals globally.

Commitment to Open Access

Since its inception, the International Journal of NeuroOncology and Therapeutics has upheld a steadfast commitment to open access principles. We believe in the universal accessibility of knowledge, enabling unrestricted access to our research publications. By adopting the Creative Commons Attribution 4.0 International License (CC BY 4.0), we empower researchers to freely share their findings, thereby catalyzing innovation and advancing neuro-oncology practices worldwide.

Technological Advancements

Embracing technological advancements, the International Journal of NeuroOncology and Therapeutics continually enhances its online platform to optimize user experience. Our robust infrastructure includes advanced search capabilities, comprehensive archives, and intuitive submission systems, facilitating seamless interaction for authors, reviewers, and readers. Through participation in LOCKSS and CLOCKSS, we ensure the perpetual preservation and accessibility of our scholarly content.

Future Directions

Looking forward, the International Journal of NeuroOncology and Therapeutics remains dedicated to advancing neuro-oncology research and clinical care through high-quality publications. We are committed to innovation, anticipating and responding to the evolving needs of our global community. Future initiatives include expanding our digital presence, launching new research initiatives, and strengthening collaborations with leading experts in neuro-oncology. Our unwavering commitment to excellence, accessibility, and ethical publishing practices will guide our continued growth and impact in the field.